Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
1970-01-01 08:00
Companies Play Catch-up as Cybersecurity Attacks Rise in Digital India
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals
1970-01-01 08:00
Moderna Signs Deal to Make mRNA Vaccines for Chinese Market
Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest
1970-01-01 08:00
OBS Group Nearing Deal for Bayer Pharma Assets in Pakistan, Sources Say
Pakistan’s OBS Group is nearing a deal to acquire pharmaceutical assets in the country from Bayer AG, according
1970-01-01 08:00
China Takes the Trade Fight to Europe, Targeting the Green Transition
China’s decision to restrict critical mineral exports will hit critical sectors in the European Union’s effort to decarbonize
1970-01-01 08:00
Monster Moves Closer to Buying Bang Energy After FTC Ends Review
Monster Beverage Corp. is moving forward with its $362 million acquisition of its bankrupt rival Bang Energy after
1970-01-01 08:00
Supreme Court Throws Out Biden’s Student-Loan Relief Plan
The US Supreme Court tossed out President Joe Biden’s plan to slash the student debt of more than
1970-01-01 08:00
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
1970-01-01 08:00
Bolsonaro to Be Banned From Public Office in Brazil for Eight Years
Brazil’s electoral court voted to ban Jair Bolsonaro from office for eight years for making false claims about
1970-01-01 08:00
Biotech Cyteir’s Drug Flop Turns Into Boon for Investors on Cash Return
A little-known biotech company, Cyteir Therapeutics Inc., notched its best day ever — on the back of plans
1970-01-01 08:00
Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
1970-01-01 08:00
DeepMind Alum Wants to Use AI to Speed the Development of Green Materials
Ever since ChatGPT went viral last fall, companies have touted many ways artificial intelligence can make our lives
1970-01-01 08:00